References
- Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS, Teng CM. Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:707-712.
-
Teng CM, Yu SM, Chen CC, Huang YL, Huang TF. EDRF-release and
$Ca^{2+}$ -channel blockade by magnolol, an anti-platelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 1990;47:1153-1161. https://doi.org/10.1016/0024-3205(90)90176-R - Fujita S, Taira J. Biphenyl compounds are hydroxy radical scavengers: their effective inhibition for UV-induced mutation in Salmolella typhimurium TA102. Free Radic. Biol Med. 1994;17:273-277. https://doi.org/10.1016/0891-5849(94)90083-3
- Wang JP, Lin PL, Hsu MF, Chen CC. Possible involvement of protein kinase C inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat. J Pharm Pharmacol. 1998;50:1167-1172. https://doi.org/10.1111/j.2042-7158.1998.tb03329.x
- Wang JP, Hsu MF, Raung SL, Chang LC, Tsao LT, Lin PL, Chen CC. Inhibition by agnolol of formylmethionyl- leucyl-phenylalanine-induced respiratory burst in rat neutrophils. J Pharm Pharmacol. 1999;51:285-294. https://doi.org/10.1211/0022357991772466
- Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. Magnolol attenuates VCAM-1 expression in vitro in TNF-a-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol. 2002;135:37-47. https://doi.org/10.1038/sj.bjp.0704458
- Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, Yoshikawa M. Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull. 2001;49:716-720. https://doi.org/10.1248/cpb.49.716
- Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D. Anti- inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med. 2005;71:338-343. https://doi.org/10.1055/s-2005-864100
- Rietschel ET, Brade H. Bacterial endotoxins. Sci Am. 1992;267:54-61.
- Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666. https://doi.org/10.1038/333664a0
- Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for Larginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987;235:473-476. https://doi.org/10.1126/science.2432665
- Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA. 1993;90:9730-9734. https://doi.org/10.1073/pnas.90.20.9730
- Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269:4705-4708.
- Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen- activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995; 270:7420-7426. https://doi.org/10.1074/jbc.270.13.7420
- Lee JC, Young PR. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol. 1996;59:152-157. https://doi.org/10.1002/jlb.59.2.152
- Da Silva J, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem. 1997;272:28373-28380. https://doi.org/10.1074/jbc.272.45.28373
- Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide snthase induction mediated by lipopolysaccharide in RAW 264.7 cells. Mol Pharmacol. 1999;55:481-488.
- Jeon YJ, Yang KH, Pulaski JT, Kaminski NE. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation. Mol Pharmacol. 1996;50:334-341.
- Xie H, Chiles TC, Rothstein TL. Induction of CREB activity via the surface Ig receptor of B cells. J Immunol. 1993;151:880-889.
- Jeon YJ, Han SH, Lee YW, Yea SS, Yang KH. Inhibition of NF-kappa B/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression. Biochem Mol Biol Int. 1998;45:435-441.
- Ruppert J, Welch W, Jain AN. Automatic identification and representation of protein binding sites for molecular docking. Protein Sci. 1997;6:524-533.
- Dunnett M. A multiple comparison procedure for comparing several treatments with a control. J Am Statistics Assoc. 1955;50:1096-1121. https://doi.org/10.2307/2281208
- Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995; 364:229-233. https://doi.org/10.1016/0014-5793(95)00357-F
- Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1995;92:7686-7689. https://doi.org/10.1073/pnas.92.17.7686
- Jeon YJ, Kim YG, Lee M, Park SM, Han SB, Kim HM. Radicicol suppresses expression of inducible nitric oxide synthase by blocking p38 kinase and nuclear factor-kB/Rel in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther. 2000;294:548-554.
- Foey AD, Parry S, Williams LM, Feldmann M, Foxwel IBM, Brennan FM. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-a: Role of the p38 and p442/44 mitogen-activated protein kinases. J Immunol. 1998;160:920-928.
- Beyaert F, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996;15:1914-1923.
- Chae HJ, Kim HK, Lee WK, Chae SW. Bolckade of p38 Mitogen-activated protein kinase pathway inhibits interleukin-6 release and expression in primary neonatal cardiomyocytes. Korean J Phyiol Pharmacol. 2002;6:319-325.
Cited by
- Macrophage activation by glycoprotein isolated from Dioscorea batatas vol.27, pp.3, 2010, https://doi.org/10.5487/tr.2011.27.3.167
- Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells vol.311, pp.1, 2010, https://doi.org/10.1016/j.canlet.2011.06.007
- Key Role of Nuclear Factor-κB in the Cellular Pharmacokinetics of Adriamycin in MCF-7/Adr Cells: The Potential Mechanism for Synergy with 20(S)-Ginsenoside Rh2 vol.40, pp.10, 2010, https://doi.org/10.1124/dmd.112.045187
- Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways vol.145, pp.1, 2010, https://doi.org/10.1016/j.jep.2012.10.051
- Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells vol.21, pp.4, 2010, https://doi.org/10.4062/biomolther.2013.044
- Magnolol Inhibits LPS-Induced Inflammatory Response in Uterine Epithelial Cells : Magnolol Inhibits LPS-Induced Inflammatory Response vol.36, pp.5, 2013, https://doi.org/10.1007/s10753-013-9631-1
- Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature vol.7, pp.11, 2010, https://doi.org/10.1158/1940-6207.capr-14-0136
- Magnolol Inhibits Tumor Necrosis Factor-α-Induced ICAM-1 Expression via Suppressing NF-κB And MAPK Signaling Pathways in Human Lung Epithelial Cells vol.37, pp.6, 2010, https://doi.org/10.1007/s10753-014-9928-8
- Magnolol Attenuates Cisplatin-Induced Muscle Wasting by M2c Macrophage Activation vol.11, pp.None, 2020, https://doi.org/10.3389/fimmu.2020.00077